Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insulin glargine and malignancy: an unwarranted alarm.

× No keyword cloud information.

55 in total

1. Insulin glargine and incidence of cancer--an ongoing debate.

Authors: Norbert Hermanns; Bernd Kulzer
Journal: J Diabetes Sci Technol Date: 2010-03-01

2. Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations.

Authors: J A Johnson; Y Yasui
Journal: Diabetologia Date: 2010-06-04 Impact factor: 10.122

Review 3. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.

Authors: Davide Soranna; Lorenza Scotti; Antonella Zambon; Cristina Bosetti; Guido Grassi; Alberico Catapano; Carlo La Vecchia; Giuseppe Mancia; Giovanni Corrao
Journal: Oncologist Date: 2012-05-29

4. Diabetes therapy and cancer risk: causal effects and other plausible explanations.

Authors: S Hernández-Díaz; H-O Adami
Journal: Diabetologia Date: 2010-02-23 Impact factor: 10.122

5. Cancer risk in type 2 diabetes.

Authors: Alice P S Kong; Juliana C N Chan
Journal: Curr Diab Rep Date: 2012-08 Impact factor: 4.810

6. Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysis.

Authors: J M Ritter
Journal: Br J Clin Pharmacol Date: 2009-11 Impact factor: 4.335

7. Supramolecular protein engineering: design of zinc-stapled insulin hexamers as a long acting depot.

Authors: Nelson B Phillips; Zhu-li Wan; Linda Whittaker; Shi-Quan Hu; Kun Huang; Qing-xin Hua; Jonathan Whittaker; Faramarz Ismail-Beigi; Michael A Weiss
Journal: J Biol Chem Date: 2010-02-24 Impact factor: 5.157

8. Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine.

Authors: J M Nagel; U Mansmann; K Wegscheider; J Röhmel
Journal: Diabetologia Date: 2009-09-24 Impact factor: 10.122

9. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications.

Authors: Ming Zhao; Zhu-li Wan; Linda Whittaker; Bin Xu; Nelson B Phillips; Panayotis G Katsoyannis; Faramarz Ismail-Beigi; Jonathan Whittaker; Michael A Weiss
Journal: J Biol Chem Date: 2009-09-22 Impact factor: 5.157

10. Insulin glargine controversy: a tribute to the editorial team at Diabetologia.

Authors: Peter C Butler
Journal: Diabetes Date: 2009-11 Impact factor: 9.461